Teva’s migraine drug Ajovy (fremanezumab) has been approved in Europe, taking on rivals from the same class from Novartis and Eli Lilly. Novartis already has Aimovig (erenumab) approved in ...
Teva’s migraine drug Ajovy (fremanezumab) has moved closer to the EU market after the influential CHMP regulatory committee gave it the green light. The decision paves the way for European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback